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Ribonucleic Acid Synthesis of Vesicular Stomatitis Virus, 
II. An RNA Polymerase in the Virion* 
David Baltimore, Alice S. Huang, and Martha Stampfer 
DEPARTMEN'r OF BIOLOGY, MASSACHUSETTS INSTITUTE OF TECHNOLOGY, CAMBRIDGE 
Communicated by S. E. Luria, March 24, 1970 
Abstract. The virions of vesicular stomatitis virus contain an enzyme that 
catalyzes the incorporation of ribonucleotides into RNA. The product of the 
reaction is mainly RNA complementary in base sequence to that of vesicular 
stomatitis virus RNA. 
Introduction. Two considerations led us to search for an RNA polymerase in 
the virion of vesicular stomatitis virus, a single-stranded RNA virus. First, the 
lack of infectivity of vesicular stomatitis virus RNA,t which contrasts with the 
readily demonstrable infectivity of RNA from arboviruses2 or picornaviruses, 3 
could be explained by an obligate requirement for a virion polymerase in order to 
initiate a vesicular stomatitis virus infection. Second, the recent finding that 
the messenger RNA's that synthesize vesicular stomatitis virus proteins are com-
plementary to the nucleotide sequence of the virion RNA 4 led us to wonder how 
the initial stages of the infection proceed: if the virion RNA is not a messenger, 
then it must be able to serve as template for messenger RNA synthesis using 
either a polymerase found in the host cell or one that is a part of the virion. 
Two precedents exist for the association of an RNA polymerase with the virion 
of an animal virus. One is the finding of a DNA-dependent RNA polymerase in 
vaccinia virions.5 The second is the finding of an RNA-dependent RNA poly-
merase in the virions of reovirus6 and other double-stranded RNA viruses.7 
Materials and Methods. Purified B particles8 of vesicular stomatitis virus, the 
Indiana serotype, 9 were used throughout these experiments. Details of the growth 
of high titered viral stocks in Chinese hamster ovary cells and purification of the virions 
through sucrose gradients were as previously described10 except for some modifications 
(manuscript in preparation). A single virus stock was used for all the experiments re-
ported in this paper, although experiments with other stocks have given comparable re-
sults. The stock contained 0.5 mg of protein/ml and 1010 plaque-forming units/ml. 
Protein was determined by the method of Lowry et al. 11 
Stocks of purified Newcastle disease virus, type N, and Sindbis virus were kindly pro-
vided by Dr. Michael A. Bratt and Dr. Boyce W. Burge, respectively. 
Reagents were obtained from the following sources: unlabeled nucleoside triphosphates 
from P-L Biochemicals; [8H]GTP from New England Nuclear; Triton N-101, deoxy-
ribonuclease and ribonuclease from Sigma. Actinomycin was a gift from Merck, 
Sharpe and Dohme. Rifampicin was supplied by Dr. Harvey Lodish. 
Results. Addition of intact, purified vesicular stomatitis virus to the appro-
priate reaction mixture led to incorporation of [3H]GMP into an acid-insoluble 
form (Table 1). The reaction was almost totally dependent on the presence of a 
detergent, whose role was presumably to strip off the outer lipid-containing en-
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velope of the virion, exposing the nucleocapsid. Triton N-101, used in these 
experiments, can be replaced by other nonionic detergents but not by sodium 
deoxycholate. 
Virtually no incorporation occurred if MgH, UTP, or CTP was omitted from 
the reaction mixture. MnH did not replace MgH and, in fact, inhibited the 
reaction if added together with MgH. The optimum MgH concentration for 
incorporation was 4-6 mM (Fig. 1). There was a partial dependence for activity 
on mercaptoethanol and either N aCl or KCl strongly stimulated incorporation. 
As expected for the properties of an RNA-dependent synthesis of RNA, the 
addition of deoxyribonuclease, actinomycin D, or rifampicin to the reaction 
mixture did not inhibit incorporation. However, the reaction was totally sensi-
tive to ribonuclease (Table 1). 
TABLE 1. Properties of the ve8icular stomatitis uirus RNA polymerase. 
Reaction system 
Complete 
Minus Triton N-101 
MinusMgCl, 
Minus MgCl,, plus 1.6 ,.moles MnCl2 
Minus UTP 
MinusCTP 
Minus virions 
Minus mercaptoethanol 
Minus NaCl 
Minus NaCl, plus 30 ,.moles KCl 
Plus 10 ,.g ribonuclease 
Plus 20 ,.g deoxyribonuclease 
Plus 5 ,.g actinomycin D 
Plus 5 ,.g rifampicin 
mpmoles GMP incorporation 
(mg protein/20 min) 
12.4 
0.38 
<0.20 
<0.20 
<0.20 
0.26 
<0.20 
7.4 
1.9 
12.0 
0.46 
12.0 
13.0 
12.6 
The complete reaction mixture consisted of the following components in a total volume of 0.3 ml: 
15 pmoles Tris-HCI, pH 7.9; 1.6 pmoles MgCI.s; 1 pmole mercaptoethanol; 30 pmoles NaCl; 0.2 
pmole of ATP, UTP, and CTP; 0.02 pmole of [•H]GTP (28.7 cpm/ ppmole); 0.25 mg Triton N-101 
and 10 pg of viral protein. The reaction mixture was incubated at 37°C for 20 min. The reaction 
was terminated by chilling in an ice bath, adding 0.5 ml of 0.08 M Na pyrophosphate, mixing, add-
ing 0.05 ml of 4 mg/ml yeast RNA, and finally precipitating with 0.5 ml of 25% trichloroacetic acid. 
Mter at least 10 min at 4°C, the samples were filtered through a Millipore filter, type HA, and the 
trapped precipitate was assayed for radioactivity in a scintillation spectrometer at 28% efficiency -
after digestion with 0.4 ml of concentrated NH,OH for 30 min and addition of 10 ml of cocktail D 
(5 gm PPO and 100 gm naphthalene in 1liter of p-dioxane). An unincubated sample contained less 
than 3% of the radioactivity of an incubated sample and this value was subtracted from all of the 
experimental values. 
The kinetics of incorporation are shown in Figure 2. Although the maximal 
rate was maintained only for 20 min, there was a long period of continued incor-
poration at a slower rate. The absence of a lag before the maximal rate was 
reached sugges~ that the detergent activation was an instantaneous process. 
Figure 3 shows the incorporation relative to the amount of added vesicular 
stomatitis virus, expressed as micrograms of viral proteins. For unknown rea-
sons, the rute of the reaction was not exactly proportional to protein concentra-
tion. 
In order to determine if the polymerase was located in virions we centrifuged a 
previously purified preparation of virions through a sucrose gradient_ and as-
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FIG. !.-Vesicular stomatitis virus RNA polymerase activity at different concentrations of 
MgH. Reaction mixtures were incubated under standard conditions (see Table 1) with 
different concentrations of MgCls. 
FIG. a.-Incorporation by different amounts of vesicular stomatitis virus virions. Reaction 
conditions were as described in Table 1. 
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FIG. 2.-Incorporation by the vesicular stomatitis virus RNA polymerase after different 
times of incubation. Reaction mixtures were incubated under standard conditions (see 
Table 1) for different lengths of time. All the chemical components of the reaction mixture 
were brought to 37°C and incorporation was initiated by the addition of virus. 
FIG. 4.-Location of vesicular stomatitis virus RNA polymerase activity by sucrose gra-
dient sedimentation of the virions. A purified vesicular stomatitis virus preparation (0.25 ml 
containing 0.375 mg protein) was layered over a 5-40% sucrose gradient in 0.13 M NaCl, 
0.003 M KCl, 0.005 M Na phosphate buffer, pH 7.4, 0.02% EDTA. The 17-mlgradient was 
centrifuged for 2.25 hr at 18,000 rpm in a small bucket of the SW 27 Spinco rotor. Frac-
tions of 1 ml were collected and 0.2-ml portions were assayed in the standard reaction mix-
ture lacking NaCl (the NaCl in the gradient provided sufficient salt) (e-e). The virions 
were identified by measuring the absorbance of fractions at 240 mp (mainly light scattering) 
(o---o). 
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sayed fractions for activity (Fig. 4). The peak of absorbance due to virions coin-
cided with the peak of RNA polymerase activity, suggesting that the enzyme 
was an integral part of the virion. The template for the incorporation was pre-
sumably the viral RNA because no template RNA was added to the reaction 
mixtures. 
The nature of the polymerase product was examined by determining its sensi-
tivity to ribonuclease and its ability to anneal to vesicular stomatitis virus RNA 
(Table 2). The RNA product obtained from a 30-min reaction mixture was less 
TABLE 2. Annealing of polymerase products with vesicular stomatitis virus RNA. 
Treatment 
(1) None 
(2) Boiled and quickly chilled 
(3) Boiled and annealed 
(4) As (3); annealed for 290 min 
(5) Boiled and annealed with VSV-RNA 
(6) Boiled and annealed with poliovirus RNA 
Ribonuclease-resistance 
(%) 
8.8 
4.5 
20 
20 
94 
21 
A standard reaction mixture containing 50 l'g of viral protein and [•H ]GTP at 73.2 cpm/ l'l'ffiOle 
was incubated for 30 min at 37°C. It was then chilled, brought to 0.1% sodium dodecyl sulfate, 
and precipitated with 2 vol of ethanol and carrier yeast transfer RNA. The labeled RNA was dis-
solved in HaO. 
Mixtures were made containing about 4000 cpm of the reaction product and either 8 ~ of vesicu-
lar stomatitis virus RNA, or 8 l'g of poliovirus RNA, or no added RNA. They were brought to 
0.1% sodium dodecyl sulfate in a final volume of 0.4 ml of H.O. As indicated in .the table, certain 
samples were boiled for 8 min and then annealed for 120minat70°Cafteraddition of 0.1 ml of a solu-
tion of 1.5 M NaCl and 0.15 M Na citrate. The samples were chilled and divided into two equal 
portiolll!, one of which was treated with 50 l'g/ml of ribonuclease A for 30 min at 22°C. All samples 
were then acid precipitated and assayed as described for Table 1. The results are expressed as per~ 
centage of ribonuclease-resistant RNA in e~ch sample. 
than 10% resistant to the action of ribonuclease. When the product was al-
lowed to self-anneal at 70°C for 2 hr, ribonuclease resistance reached a level of 
20% but did not increase further when annealing was continued for a longer time. 
When annealed with added unlabeled vesicular stomatitis virus RNA, the product 
became almost entirely resistant to ribonuclease. Neither poliovirus RNA nor 
ribosomal RNA from Chinese hamster ovary cells caused any increase in ribo-
nuclease resistance. The product appears, therefore, to be mostly single-stranded 
RNA complementary in sequence to vesicular stomatitis virus RNA. 
Preparations of virions of Newcastle disease virus and Sindbis virus, which had 
been purified by sucrose gradient centrifugation, were tested for RNA polymerase 
activity using the standard vesicular stomatitis virus polymerase assay conditions 
(see Table 1). No activity was demonstrable with these preparations, indicating 
that they had less than 2% of the specific activity of vesicular stomatitis virus 
preparations per milligram of protein. The Newcastle disease virus preparation 
was tested more extensively: neither omitting the NaCl from the reaction mix-
ture nor omitting the detergent revealed any activity and the Newcastle disease 
virus was not inhibitory to the vesicular stomatitis virus polymerase when the 
two viral preparations were mixed. 
Discussion. The RNA polymerase described here appears to be inside the 
vesicular stomatitis virion and to use the vesicular stomatitis virus RNA as 
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template for the synthesis of complementary RNA. This statements follows 
from the co-sedimentation of virions and polymerase activity, the lack of sensi-
tivity to inhibitors of DNA-dependent RNA synthesis, and the ability of the 
RNA product to form a ribonuclease-resistant complex with vesicular stomatitis 
virus RNA. 
Experiments to be published suggest that complementary RNA serves as 
messenger for the translation of viral proteins in vesicular stomatitis virus-in-
fected cells. Since the product of the polymerase found in the virions is also 
complementary RNA, it is likely that this enzyme is a transcriptase rather than 
a replicase. Whether a second RNA polymerase exists in infected cells is not 
known. Likewise, the relation of the virion polymerase to the cytoplasmic poly-
merase that has been demonstrated in vesicular stomatitis virus-infected cells12 
is not clear. 
Our inability to anneal more than 20% of the product to the endogenous tem-
plate (Table 2, lines 3 and 4) suggests that the in vitro reaction leads to the syn-
thesis of more than one copy of the region of the vesicular stomatitis virus RNA 
which is transcribed. We do not know, however, whether all of the vesicular 
stomatitis virus RNA is being copied or merely a portion of it. 
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